New comments outline ways to counteract cost-shifting insurance trends

PhRMA submitted comments this week in response to the Department of Health & Human Services’ (HHS) 2023 Notice of Benefit and Payment Parameters (NBPP) proposed rule. As outlined in our comments,...
Read More
Patients need to pay less for their medicines. States can help.

No one should struggle to afford the medicines they need. Unfortunately, some patients continue to bear more of their medicine costs at the pharmacy counter. Patients with deductibles have seen their...
Read More
CBO reaffirms our innovation ecosystem leads to improved lives, long-term savings

The Congressional Budget Office (CBO) recently released a new report looking at trends in spending, prices and use of prescription drugs. While some politicians are trying to use the report to...
Read More
The patient experience: Insurance design hurdles lead to access issues for too many Americans, including communities of color and the chronically ill.

3 in 10 insured Americans still face a financial barrier to care and some of the most vulnerable patients are also those more likely to experience barriers in accessing their care, according to our...
Read More
New report: To drive up profits, hospitals continue unnecessary medicine mark-ups, burdening patients, employers and the health system

A new study from the Employee Benefit Research Institute (EBRI) compared the difference in price for 72 physician-administered outpatient medicines – representing 73% of medicine spending – depending...
Read More
Election insights: Voter priorities in the states

In the 2020 election, Americans nationwide cast their ballots with two major issues on their minds – the economy and coronavirus. Health care specific concerns centered on pre-existing conditions...
Read More
PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs

Yesterday, PhRMA submitted comments on the Department of Health & Human Services’ (HHS) 2021 Notice of Benefit and Payment Parameters proposed rule. The proposed rule would hurt patients’ ability to...
Read More
New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers

A new whitepaper authored by Bruce Pyenson, F.S.A., M.A.A.A. and colleagues from Milliman explains why Institute for Clinical and Economic Review (ICER) cost-effective analyses (CEAs) will not be...
Read More
Copay coupons can help ease patients’ out-of-pocket costs

Each year, middlemen, like pharmacy benefit managers (PBMs) and insurers, shift more of the costs of health care to patients. Ensuring patients have affordable access to their medicines is the top...
Read More
ICYMI: New report outlines steps for greater transparency in health care

Last week, The Network for Excellence in Health Innovation (NEHI) released a new report that outlines steps for greater transparency in health care. The report states that helping consumers make...
Read More